The only constant in the management of retinal disease is change. Dr. Randall Funderburk will present the pathophysiology of diabetic eye disease as it is currently understood. He will discuss current evidence-based diagnostic and management strategies as well as evolving/future approaches for evaluation and treatment of diabetic retinopathy.
There is a continuous evolution of lens technology which attempts to correct higher order aberrations as well as the presbyopia induced by traditional IOL technology. Dr. Lee McDaniel will review the latest technologies that are available as well as discuss future technologies that are either in the FDA approval process or already have CE approval in Europe.